HGC Investment Management Inc. - PHOENIX BIOTECH ACQUISITION ownership

PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K105. A total of 18 filers reported holding PHOENIX BIOTECH ACQUISITION in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
HGC Investment Management Inc. ownership history of PHOENIX BIOTECH ACQUISITION
ValueSharesWeighting
Q4 2022$10,180
-99.8%
1,000,000
+100.0%
0.44%
+30.5%
Q3 2022$5,045,000
-49.6%
500,000
-50.0%
0.34%
+11.4%
Q2 2022$10,013,000
+100.1%
1,000,000
+100.0%
0.31%
+2.3%
Q1 2022$5,003,000500,0000.30%
Other shareholders
PHOENIX BIOTECH ACQUISITION shareholders Q1 2023
NameSharesValueWeighting ↓
Sea Otter Advisors LLC 124,500$1,256,0002.63%
Lynwood Capital Management Inc. 39,615$400,0000.44%
METEORA CAPITAL, LLC 164,721$1,662,0000.42%
Sage Rock Capital Management LP 183,998$1,857,0000.41%
HGC Investment Management Inc. 500,000$5,045,0000.34%
MMCAP International Inc. SPC 370,000$3,733,0000.30%
Bulldog Investors, LLP 97,364$982,0000.29%
Atalaya Capital Management LP 200,000$2,020,0000.27%
Context Capital Management, LLC 400,000$4,036,0000.27%
PERISCOPE CAPITAL INC. 752,259$7,590,0000.22%
View complete list of PHOENIX BIOTECH ACQUISITION shareholders